5 min listen
OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
ratings:
Length:
5 minutes
Released:
Jun 1, 2023
Format:
Podcast episode
Description
In this week’s podcast, Neurology Today’s editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Released:
Jun 1, 2023
Format:
Podcast episode
Titles in the series (99)
April 2, 2020 Issue Introduction by Neurology Today in 5